open access

Vol 29, No 6 (2022)
Letter to the Editor
Submitted: 2022-06-16
Accepted: 2022-09-29
Published online: 2022-10-27
Get Citation

Chosen laboratory markers as a determinant of COVID-19 severity

Ihor Navolokin1, Oleksandra Tuboltseva1, Alla Navolokina2
DOI: 10.5603/CJ.a2022.0099
·
Pubmed: 36342033
·
Cardiol J 2022;29(6):1049-1050.
Affiliations
  1. School of Medicine, International European University, Kyiv, Ukraine
  2. Department of Public Health and Social Medicine, International European University, Kyiv, Ukraine

open access

Vol 29, No 6 (2022)
Letters to the Editor — COVID-19
Submitted: 2022-06-16
Accepted: 2022-09-29
Published online: 2022-10-27

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Chosen laboratory markers as a determinant of COVID-19 severity

Journal

Cardiology Journal

Issue

Vol 29, No 6 (2022)

Article type

Letter to the Editor

Pages

1049-1050

Published online

2022-10-27

Page views

3201

Article views/downloads

235

DOI

10.5603/CJ.a2022.0099

Pubmed

36342033

Bibliographic record

Cardiol J 2022;29(6):1049-1050.

Authors

Ihor Navolokin
Oleksandra Tuboltseva
Alla Navolokina

References (10)
  1. Fialek B, Pruc M, Smereka J, et al. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol J. 2022; 29(5): 751–758.
  2. Dzieciatkowski T, Szarpak L, Filipiak KJ, et al. COVID-19 challenge for modern medicine. Cardiol J. 2020; 27(2): 175–183.
  3. Smereka J, Szarpak L. COVID 19 a challenge for emergency medicine and every health care professional. Am J Emerg Med. 2020; 38(10): 2232–2233.
  4. Gozhenko A, Szarpak L, Jaguszewski M, et al. COVID-19 vaccine — third dose, booster dose? What is it and is it necessary? Disaster Emerg Med J. 2021; 6(4): 208–209.
  5. Szarpak L, Ruetzler K, Safiejko K, et al. Lactate dehydrogenase level as a COVID-19 severity marker. Am J Emerg Med. 2021; 45: 638–639.
  6. Yaman E, Demirel B, Yilmaz A, et al. Retrospective evaluation of laboratory findings of suspected paediatric COVID-19 patients with positive and negative RT-PCR. Disaster Emerg Med J. 2021; 6(3): 97–103.
  7. Gasecka A, Pruc M, Kukula K, et al. Post-COVID-19 heart syndrome. Cardiol J. 2021; 28(2): 353–354.
  8. Szarpak Ł, Nowak B, Kosior D, et al. Cytokines as predictors of COVID-19 severity: evidence from a meta-analysis. Pol Arch Intern Med. 2021; 131(1): 98–99.
  9. Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020; 95: 304–307.
  10. Li P, Wu W, Zhang T, et al. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care. 2021; 25(1): 158.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl